Supportive Health
Whole-person health alongside GLP-1 medications: hormones, menopause, testosterone, and the conditions that intersect with weight.
28 articles · updated Sep 26
Start here
New to GLP-1? Start here: your step-by-step learning path
Just starting out with GLP-1 medications, or still deciding? This ordered path walks you from how these medications work through access, talking to your doctor, side effects, eating well, protecting muscle with movement, setting calorie and protein targets, and the mental and social side, one step at a time.
New to GLP-1s? This guided reading path covers the basics in order.
Guides
GuideNew
CPAP as the weight comes off: managing sleep apnea on a GLP-1
Tirzepatide (Zepbound) roughly halved sleep apnea severity in the SURMOUNT-OSA trials, and 42 to 50% of participants reached the trial's definition of resolution. That still left many with apnea, and the trials never tested stopping CPAP for good. This guide covers why you shouldn't retire your machine on your own, how pressure and mask fit change as weight comes off, when and how a repeat sleep test happens, and how an OSA diagnosis affects Zepbound coverage (as of September 2026).
GuideNew
Protecting your bones on a GLP-1: bone density, fracture risk, and what actually helps
Losing a lot of weight usually costs a small amount of bone, mostly at the hip, and GLP-1 weight loss is no exception. So far the fracture data are reassuring and the drug itself does not look like the main cause, but the long-term evidence is thin. Here's what the bone-density and fracture studies show, who should pay the most attention, and the levers that kept bone steady in trials: resistance and impact training, protein, calcium and vitamin D, and a well-timed bone scan.
Guide
Physician's Choice Digestive Enzymes & 60 Billion Probiotic: are they worth it on a GLP-1?
Physician's Choice markets these two supplements together in a "Hack Your Tummy" TikTok campaign for bloating and post-meal discomfort, a real complaint for GLP-1 users. Both score 54/100 (Skip). The GI need is real, but neither label discloses per-ingredient doses (for the probiotic, per-strain CFU), the certifications cited describe the factory rather than the product, and you pay a premium for formulas you can't check against the research.
Guide
How GLP-1 medications affect men vs. women: what the sex differences actually are
The same GLP-1 medication doesn't act quite the same in men and women. On average women lose more weight, report more side effects, and absorb more of the drug at the same body weight, differences driven partly by estrogen and testosterone. This guide covers what the research shows about sex differences in weight loss, tolerability, blood sugar and biology, and what it means for what you should expect.
Guide
Women's health on a GLP-1: birth control, pregnancy, PCOS, bone, and the things worth watching
For women, the biggest GLP-1 question is fertility. Tirzepatide can make the pill less reliable, weight loss can bring back ovulation you weren't expecting, and none of these drugs is safe in pregnancy, which is why "Ozempic babies" happen. This guide covers contraception and pregnancy planning, the PCOS trial evidence, protecting bone and muscle, the heart, and the menopause overlap.
Guide
Men's health on a GLP-1: testosterone, fertility, muscle, and the things worth watching
For men, losing weight on a GLP-1 can raise testosterone that obesity was holding down, and unlike testosterone therapy it seems to leave fertility intact. This guide covers what the research shows so far on testosterone, sexual function and sperm, muscle and bone, heart health and sleep apnea, and why the routine checkup matters more on these medications.
Guide
Cortisol, stress, and weight on a GLP-1: what the connection really is
The "cortisol makes you fat" story is mostly overstated. Real cortisol excess, as in Cushing's syndrome, clearly drives central fat, but everyday stress does far less. On a GLP-1, cortisol matters more for muscle than for belly fat. This guide covers the evidence, how sleep affects cortisol, and why "cortisol-blocker" supplements don't hold up.
Guide
Getting a sleep study: what to expect and how coverage works
If a GLP-1 has you asking about a sleep study, this is the practical map: why apnea matters more now that one of these drugs treats it, the two kinds of study and what each night is like, the AHI number that grades the result, and how referral and insurance coverage usually work.
Guide
Sleep quality on a GLP-1: why it matters, what changes, and the sleep apnea connection
Sleep is the quiet variable in GLP-1 treatment. Short sleep can shift weight loss away from fat and toward muscle, GI side effects and hunger changes can disturb the night, and one GLP-1 medication is now FDA-approved to treat obstructive sleep apnea itself. This guide covers how sleep stages work, how treatment can affect them, and why protecting deep sleep helps protect your muscle.
Guide
Hormone replacement therapy (HRT) and GLP-1 medications: an overview
HRT and GLP-1s keep coming up together because the times people look at hormones (menopause in women, low testosterone in men) are also times of weight and body-composition change. This overview explains what each does, who benefits, what weight loss does to testosterone, and how to plan the two together.
Guide
HRT for men (testosterone) and GLP-1 medications: what the connection really is
Low testosterone and excess weight are linked, but the cause often runs from the weight to the testosterone, and that changes when testosterone therapy actually helps. This guide covers who benefits from TRT and why losing weight on a GLP-1 can raise testosterone on its own.
Guide
HRT for women and GLP-1 medications: menopause, weight, and body composition
Menopause shifts where the body stores fat and how well it holds muscle, the same ground a GLP-1 works on, so hormone therapy often comes up. This guide explains what HRT is for women, who benefits, the 2025–2026 FDA label changes, and how HRT does and doesn't overlap with GLP-1 weight management.
Glossary terms
- LH and FSH · Luteinizing hormone and follicle-stimulating hormone: two pituitary hormones that signal the testes and ovaries to make sex hormones and sperm or eggs.
- CPAP · Continuous positive airway pressure: a bedside machine that blows gently pressurized air through a mask to hold the airway open during sleep, the standard first-line treatment for obstructive sleep apnea.
- Polysomnography · An overnight, in-lab sleep study that records brain activity, breathing, blood oxygen, heart rhythm, and movement to diagnose sleep disorders — the gold-standard test for obstructive sleep apnea.
- Functional hypogonadism · Reduced testosterone in men that results from a reversible cause such as obesity, type 2 diabetes, or sleep apnea rather than damage to the hormonal axis; it typically improves with weight loss and is not an indication for testosterone therapy.
- Cushing's syndrome · A condition of persistently excessive cortisol, caused by a hormone-producing tumor or long-term glucocorticoid medication, producing central weight gain, a rounded face, easy bruising, and muscle weakness — distinct from ordinary stress.
- Cortisol · The main glucocorticoid hormone, released by the adrenal glands on a daily rhythm to raise blood sugar, sharpen alertness, and manage stress; chronically high levels break down muscle and, in true excess, drive central fat.
- Apnea-hypopnea index (AHI) · The number of complete (apnea) and partial (hypopnea) breathing interruptions per hour of sleep, measured in a sleep study; it grades obstructive sleep apnea as mild (5–14), moderate (15–29), or severe (30+).
- Polycystic ovary syndrome (PCOS) · A common hormonal condition in women involving irregular or absent periods, higher androgen levels, and frequently insulin resistance and weight gain; GLP-1 medications are increasingly used for weight management in PCOS.
- Visceral fat · Fat stored deep in the abdomen around the internal organs, which is more strongly tied to metabolic and cardiovascular risk than fat under the skin.
- Obstructive sleep apnea · A sleep disorder in which the airway repeatedly collapses during sleep, causing brief pauses in breathing; it is closely linked to obesity.
- Progestogen · A hormone — natural progesterone or a synthetic progestin — given alongside estrogen in menopausal hormone therapy to protect the lining of the uterus.
- SHBG (sex hormone-binding globulin) · A protein that binds and transports sex hormones (including testosterone) in the blood. Obesity lowers SHBG, which reduces measured total testosterone and is a major reason obesity can look like low testosterone on a lab test.
- Hypogonadism · A condition of low sex-hormone production. In men it means low testosterone with symptoms; importantly, the low testosterone that often accompanies obesity is frequently a reversible state ('pseudo-hypogonadism') rather than true, pathologic hypogonadism.
- Testosterone replacement therapy (TRT) · Replacing testosterone in men who have hypogonadism (clinically low testosterone plus symptoms), delivered as a gel, injection, patch, or pellet. It is for a specific diagnosis, not a default treatment for the reversible low testosterone that often accompanies obesity.
- Menopausal hormone therapy (MHT) · Estrogen, usually combined with a progestogen (when the uterus is present), used to relieve menopausal symptoms such as hot flashes and to protect bone. Often just called 'HRT.' It is associated with less visceral fat but is not a weight-loss treatment.
- Hormone replacement therapy (HRT) · Treatment that replaces a hormone the body no longer produces in adequate amounts — most commonly estrogen (usually with a progestogen) for menopausal women, or testosterone for men with hypogonadism. It is not a weight-loss treatment and is separate from GLP-1 medications.